Vnitr Lek 2015, 61(1):10-12

Surprisingly old skeleton in the cupboard - editorial

Petr Sucharda
III. interní klinika 1. LF UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA

Received: July 22, 2014; Published: January 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sucharda P. Surprisingly old skeleton in the cupboard - editorial. Vnitr Lek. 2015;61(1):10-12.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Johnson RJ, Titte S, Cade JR et al. Uric acid, evolution and primitive cultures. Semin Nephrol 2005; 25(1): 3-8. Go to original source... Go to PubMed...
    2. Koborová I, Kollárová R, Hlavatá A et al. Asymptomatická hyperurikémia a metabolický syndróm u mladistvých. Vnitř Lék 2015; 61(1): 42-49. Go to PubMed...
    3. Grayson PC, Kim SY, LaValley M et al. Hyperuricemia and incident hypertension: A systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011; 63(1): 102-110. Go to original source... Go to PubMed...
    4. Soletsky B, Feig DI. Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension 2012; 60(5): 1148-1156. Go to original source... Go to PubMed...
    5. Assadi F. Allopurinol enhances the blood pressure lowering effect of enalapril in children with hyperuricemic essential hypertension. J Nephrol 2014; 27(1): 51-56. Go to original source... Go to PubMed...
    6. Whelton A. Hyperuricemia and hypertension. A confluence of concepts. Hypertension 2012; 60(5): 1112-1113. Go to original source... Go to PubMed...
    7. Soltani Z, Rasheed K, Kapusta DR et al. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep 2013; 15(3): 175-181. Go to original source... Go to PubMed...
    8. Johnson RJ, Sánchez-Lozada LG, Mazzali M et al. What are the key arguments against uric acid as a true risk factor for hypertension? Hypertension 2013; 61(5): 948-951. Go to original source... Go to PubMed...
    9. Kanbay M, Solak Y, Gaipov A et al. Allopurinol as a kidney-protective, cardioprotective, and antihypertensive agent: hype or reality? Blood Purif 2014; 37(3): 172-178. Go to original source... Go to PubMed...
    10. Enzi G, Busetto L, Inelmen EM et al. Historical perspective: visceral obesity and related comorbidity in Joannes Baptista Morgagni's "De sedibus et causis morborum per anatomen indagata". Int J Obes Relat Metab Disord 2003; 27(4): 534-535. Go to original source... Go to PubMed...
    11. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37(12): 1595-1607. Go to original source... Go to PubMed...
    12. Alberti KG, Eckel RH, Grundy SM et al. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120(16): 1640-1645. Go to original source... Go to PubMed...
    13. Sucharda P. Metabolický syndrom - kliniku patofyziologií nenahradíš. Practicus 2014; 13(4): 14-15.
    14. Poyrazoglu S, Bas F, Darendeliler F. Metabolic syndrome in young people. Curr Opin Endocrinol Diabetes Obes 2014; 21(1): 56-63. Go to original source... Go to PubMed...
    15. Zimmet P, Alberti G, Kaufman F et al. International Diabetes Federation Task Force on Epidemiology and Prevention of Diabetes. The metabolic syndrome in children and adolescents. Lancet 2007; 369(9579): 2059-2061. Go to original source... Go to PubMed...
    16. Billiet L, Doaty S, Katz JD et al. Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol 2014; 2014: 852954. Dostupné z DOI: <http://dx.doi.org/10.1155/2014/852954>. Go to original source... Go to PubMed...
    17. Johnson RJ, Perez-Pozo SE, Sautin YY et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev 2009; 30(1): 96-116. Go to original source... Go to PubMed...
    18. Johnson RJ, Nakagawa T, Sanchez-Lozada LG et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 2013; 62(10): 3307-3315. Go to original source... Go to PubMed...
    19. Bray GA. Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people. Adv Nutr 2013; 4(2): 220-225. Go to original source... Go to PubMed...
    20. Guthrie JF, Morton JF. Food sources of added sweeteners in the diets of Americans. J Am Diet Assoc 2000; 100(1): 43-51. Go to original source... Go to PubMed...
    21. Stanhope KL, Schwarz JM, Keim NL et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009; 119(5): 1322-1334. Go to original source... Go to PubMed...
    22. Kratzer JT, Lanaspa MA, Murphy MN et al. Evolutionary history and metabolic insights of ancient mammalian uricases. Proc Natl Acad Sci USA 2014; 111(10): 3763-3768. Go to original source... Go to PubMed...
    23. Watanabe S, Kang DH, Feng L et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002; 40(3): 355-360. Go to original source... Go to PubMed...
    24. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359(17): 1811-1821. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.